These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1896771)

  • 1. Chemotherapy of CNS-trypanosomiasis: the combined use of the arsenicals and nitro-compounds.
    Jennings FW
    Trop Med Parasitol; 1991 Jun; 42(2):139-42. PubMed ID: 1896771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin.
    Jennings FW
    Trop Med Parasitol; 1991 Sep; 42(3):157-60. PubMed ID: 1801135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanocidal activity of a 5-substituted 2-nitroimidazole compound (Ro 15-0216) in mice.
    Zweygarth E; Röttcher D
    Trop Med Parasitol; 1987 Sep; 38(3):171-4. PubMed ID: 3432951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future prospects for the chemotherapy of human trypanosomiasis. 2. Combination chemotherapy and African trypanosomiasis.
    Jennings FW
    Trans R Soc Trop Med Hyg; 1990; 84(5):618-21. PubMed ID: 2278054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Action of drugs tested in an acellular medium and in mice infected with Trypanosoma brucei brucei].
    Bouteille B; Darde ML; Pestre-Alexandre M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):533-42. PubMed ID: 3143489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of DL-alpha-difluoromethylornithine against susceptible and drug-resistant Trypanosoma brucei brucei.
    Zweygarth E; Kaminsky R
    Acta Trop; 1991 Jan; 48(3):223-32. PubMed ID: 1671624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential sensitivity of Trypanosoma brucei rhodesiense isolates to in vitro lysis by arsenicals.
    Yarlett N; Goldberg B; Nathan HC; Garofalo J; Bacchi CJ
    Exp Parasitol; 1991 Feb; 72(2):205-15. PubMed ID: 1849084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice.
    Jennings FW; Urquhart GM
    Z Parasitenkd; 1983; 69(5):577-81. PubMed ID: 6636983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-resistance to nitro drugs and implications for treatment of human African trypanosomiasis.
    Sokolova AY; Wyllie S; Patterson S; Oza SL; Read KD; Fairlamb AH
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2893-900. PubMed ID: 20439607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.
    Barrett MP; Fairlamb AH
    Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of 2-substituted 5-nitroimidazoles in the treatment of chronic murine Trypanosoma brucei infections with central nervous system involvement.
    Jennings FW; Urquhart GM; Murray PK; Miller BM
    Z Parasitenkd; 1984; 70(6):691-7. PubMed ID: 6524019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combination of DFMO and diminazene aceturate in the treatment of late stage Trypanosoma brucei brucei infection in rats.
    Onyeyili PA; Onwualu JE
    Trop Med Parasitol; 1991 Jun; 42(2):143-5. PubMed ID: 1896772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
    Jennings FW; Rodgers J; Bradley B; Gettinby G; Kennedy PG; Murray M
    Parasitol Int; 2002 Dec; 51(4):381-8. PubMed ID: 12421636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trypanocidal activity of nitroaromatic prodrugs: current treatments and future perspectives.
    Wilkinson SR; Bot C; Kelly JM; Hall BS
    Curr Top Med Chem; 2011; 11(16):2072-84. PubMed ID: 21619510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy of CNS trypanosomiasis.
    Jennings FW
    Acta Trop; 1993 Sep; 54(3-4):205-13. PubMed ID: 7902658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of sleeping sickness. Results in the Tete district].
    Neves J
    An Esc Nacl Saude Publica Med Trop (Lisb); 1970; 4(1):229-47. PubMed ID: 4252881
    [No Abstract]   [Full Text] [Related]  

  • 19. High-throughput decoding of antitrypanosomal drug efficacy and resistance.
    Alsford S; Eckert S; Baker N; Glover L; Sanchez-Flores A; Leung KF; Turner DJ; Field MC; Berriman M; Horn D
    Nature; 2012 Jan; 482(7384):232-6. PubMed ID: 22278056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy of trypanosomiasis: the use of guanylhydrazone compounds in the treatment of experimental murine trypanosomiasis.
    Jennings FW; Ulrich P; Cerami A
    Trop Med Parasitol; 1987 Sep; 38(3):181-6. PubMed ID: 3124253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.